Max Healthcare Institute Limited Q2 & H1 FY26 Concall Decoded: 20 quarters of growth, beds everywhere, cash flows temporarily on vacation

1. Opening Hook

While most hospital chains are still debating whether demand will “normalize,” Max Healthcare has quietly completed 20 straight quarters of growth and moved on to arguing about how many beds they can physically squeeze into India’s busiest pin codes. Q2 FY26 was less about survival and more about logistics—where to add beds, how fast brownfields ramp, and how much cash the government owes.

Doctors leaving? “Less than 1%.”
Insurance fights? “Happens every few years.”
CGHS revision after ages? Finally showed up with a ₹200 crore gift.

If you expected drama, management gave you spreadsheets instead. But behind the calm tone sits a machine running at 77% occupancy, expanding aggressively, and preparing for a margin kicker that hasn’t even fully landed yet. Read on—this one’s quietly powerful.

2. At a Glance

Revenue up 21% YoY: Healthcare inflation, but executed clinically.
EBITDA up 23%: Operating leverage doing its night rounds.
EBITDA margin 26.9%: Hospitals printing cash, politely.
PAT up 16% (normalized): Accounting noise aside, trend intact.
Occupancy 77%: Beds are full, complaints department busier.
Net debt ₹2,067 Cr: Capex-heavy year, CFO still sleeping fine.

3. Management’s Key Commentary

“We have delivered 20 consecutive quarters of growth.”
(Translation: This is no longer a COVID hangover story 😏)

“Existing units grew revenue by 14%.”
(Translation: Old hospitals still doing the heavy lifting.)

“Brownfield EBITDA break-even is immediate.”
(Translation: No patience required, margins show up fast.)

“CGHS revision will add over ₹200 crore.”
(Translation: Government finally adjusted the bill.)

“Doctor attrition is less than 1%.”
(Translation: HR department sleeping peacefully.)

“Cash flow weakness is institutional lumpiness.”
(Translation: PSU payments doing PSU things.)

4. Numbers Decoded

Source table

Metric	Q2 FY26	YoY Change	Decoded Meaning
Revenue	₹2,692 Cr	+21%	Demand + beds doing the job
EBITDA	₹694 Cr	+23%	Strong operating leverage
EBITDA Margin	26.9%	↑	Brownfields working
PAT (reported)	₹554 Cr	+59%	Includes ₹149 Cr one-off
PAT (normalized)	₹406 Cr	+16%	Core growth steady
Free Cash Flow	₹291 Cr	↓	Institutional receivables lag

Decoded: Ignore the one-offs—core hospital economics remain rock-solid.

5. Analyst Questions

Doctor exits in NCR?
Management: Attrition <1–1.5%.
(Translation: Noise, not signal.)
Insurance standoff impact?
Management: Shifted to self-pay, occupancy stable.
(Translation: Patients didn’t walk out.)

To Read Full 16 Point